Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI

被引:0
|
作者
Su, Min-Ying [1 ]
Baik, Hyun-Man
Yu, Hon J.
Chen, Jeon-hor
Mehta, Rita S.
Nalcioglu, Orhan
机构
[1] Univ Calif Irvine, John Tu & Thomas Yuen Ctr Funct Oncoimaging, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA
关键词
breast cancer; choline; dynamic contrast enhanced MRI; MR spectroscopic imaging; neoadjuvant chemotherapy; and pharmacokinetic parameters;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although an MRI scanner is a single stand-alone modality, different acquisition techniques may be applied to collect structural and functional information, including vascular or angiogenic properties measured by dynamic contrast enhanced MRI (DCE-MRI) and Choline (Cho) metabolism measured by proton MR spectroscopy imaging (MRSI). They may provide complementary information for a better characterization of neoplasm. In this study, we investigated the correlation between Choline measured by MRSI and vascular parameters measured by DCE-MRI in breast cancer. Fourteen patients with histologically proven invasive breast cancer were included. MRSI from a grid of 8 x 8 voxels within a selected slab from each lesion was performed. Each voxel was 1.0 x 1.0 x 1.2 cm(3). Choline signal-to-noise ratio (SNR) was measured from each voxel showing an identifiable Choline peak. Corresponding DCE kinetics was measured from each voxel, and analyzed with a 2-compartmental model to obtain pharmacokinetic parameters K-trans and k(ep). All parameters showed a wide variation within each lesion, and there were no consistent correlations between regional Cho and DCE parameters within the lesion of each individual patient. This finding might be attributed to the heterogeneous nature of breast cancer. The characteristic Cho and DCE-MRI parameters were obtained for each patient by averaging over all Cho-positive voxels. In these 14 patients there was a significant linear correlation between Cho with percent enhancement at 2 min after injection, SE%-2min (r = 0.75, p = 0.002), and pharmacokinetic parameters K-trans (r = 0.74, p = 0.003), and k(ep) (r = 0.76, p = 0.002). The results suggested that overall there is a correlation between Choline metabolism and angiogenesis activity. Since Choline is associated with cell replication and angiogenesis is required to support tumor growth, this might explain the correlation between these two sets of measures among different lesions.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 50 条
  • [1] Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer
    Li, Xia
    Welch, E. Brian
    Chakravarthy, A. Bapsi
    Xu, Lei
    Arlinghaus, Lori R.
    Farley, Jaime
    Mayer, Ingrid A.
    Kelley, Mark C.
    Meszoely, Ingrid M.
    Means-Powell, Julie
    Abramson, Vandana G.
    Grau, Ana M.
    Gore, John C.
    Yankeelov, Thomas E.
    MAGNETIC RESONANCE IN MEDICINE, 2012, 68 (01) : 261 - 271
  • [2] Comparison of Quantitative Parameters in Cervix Cancer Measured by Dynamic Contrast-Enhanced MRI and CT
    Yang, Cheng
    Stadler, Walter M.
    Karczmar, Gregory S.
    Milosevic, Michael
    Yeung, Ivan
    Haider, Masoom A.
    MAGNETIC RESONANCE IN MEDICINE, 2010, 63 (06) : 1601 - 1609
  • [3] Breast cancer in dense breast: Detection with contrast-enhanced dynamic MR imaging
    Kawashima, H
    Matsui, O
    Suzuki, M
    Kadoya, M
    Tawara, M
    Nonomura, A
    Noguchi, M
    Takashima, T
    JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 2000, 11 (03): : 233 - 243
  • [4] Dynamic Contrast-Enhanced Breast MR Imaging
    Moon, Marianne
    Cornfeld, Daniel
    Weinreb, Jeffrey
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2009, 17 (02) : 351 - +
  • [5] Dynamic contrast-enhanced MRI of prostate cancer at 3 T: A study of pharmacokinetic parameters
    Ocak, Iclal
    Bernardo, Marcelino
    Metzger, Greg
    Barrett, Tristan
    Pinto, Peter
    Albert, Paul S.
    Choyke, Peter L.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 189 (04) : W192 - W201
  • [6] Dynamic contrast-enhanced MR imaging in cancer
    O'Connor, James P. B.
    Watson, Yvonne
    Jackson, Alan
    RADIOGRAPHY, 2007, 13 : E45 - E53
  • [7] Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer
    Kuchcinski, Gregory
    Le Rhun, Emilie
    Cortot, Alexis B.
    Drumez, Elodie
    Duhal, Romain
    Lalisse, Maxime
    Dumont, Julien
    Lopes, Renaud
    Pruvo, Jean-Pierre
    Leclerc, Xavier
    Delmaire, Christine
    EUROPEAN RADIOLOGY, 2017, 27 (09) : 3733 - 3743
  • [8] New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer
    Rydland, J
    Bjornerud, A
    Haugen, O
    Torheim, G
    Torres, C
    Kvistad, KA
    Haraldseth, O
    ACTA RADIOLOGICA, 2003, 44 (03) : 275 - 283
  • [9] Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer
    Liu, Meijie
    Mao, Ning
    Ma, Heng
    Dong, Jianjun
    Zhang, Kun
    Che, Kaili
    Duan, Shaofeng
    Zhang, Xuexi
    Shi, Yinghong
    Xie, Haizhu
    CANCER IMAGING, 2020, 20 (01)
  • [10] Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer
    Meijie Liu
    Ning Mao
    Heng Ma
    Jianjun Dong
    Kun Zhang
    Kaili Che
    Shaofeng Duan
    Xuexi Zhang
    Yinghong Shi
    Haizhu Xie
    Cancer Imaging, 20